Literature DB >> 8940278

Autosomal dominant iridogoniodysgenesis anomaly maps to 6p25.

A J Mears1, F Mirzayans, D B Gould, W G Pearce, M A Walter.   

Abstract

Autosomal dominant iridogoniodysgenesis anomaly (IGDA) is characterized by iris hypoplasia and goniodysgenesis with frequent juvenile glaucoma. IGDA is the result of aberrant migration or terminal induction of the neural crest cells involved in the formation of the anterior chamber of the eye. After eliminating candidate regions for other ocular disorders, a genome-wide scan for IGDA was performed using linkage analysis. Approximately 95% of the genome was excluded with >300 microsatellite markers before significant linkage was demonstrated between IGDA and chromosome 6 markers in two families. From haplotype analysis and identification of recombinants, the IGDA locus is mapped to an 8.3-cM interval distal to D6S477, at 6p25. Our linkage results are consistent with the ocular findings in rare cases of individuals with chromosomal anomalies involving deletions of 6p. This suggests that there is a major gene involved in eye anterior segment development at 6p25.

Entities:  

Mesh:

Year:  1996        PMID: 8940278      PMCID: PMC1914875     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  23 in total

1.  The detection and estimation of linkage between the genes for elliptocytosis and the Rh blood type.

Authors:  N E MORTON
Journal:  Am J Hum Genet       Date:  1956-06       Impact factor: 11.025

Review 2.  Partial deletion of chromosome 6p: delineation of the syndrome.

Authors:  C G Palmer; P Bader; M L Slovak; D E Comings; M J Pettenati
Journal:  Am J Med Genet       Date:  1991-05-01

3.  Neural crest origin of trabecular meshwork cells and other structures of the anterior chamber.

Authors:  M I Kaiser-Kupfer
Journal:  Am J Ophthalmol       Date:  1989-06-15       Impact factor: 5.258

4.  Familial hypoplasia of the iris stroma associated with glaucoma.

Authors:  J R Weatherill; C T Hart
Journal:  Br J Ophthalmol       Date:  1969-07       Impact factor: 4.638

5.  Positional cloning and characterization of a paired box- and homeobox-containing gene from the aniridia region.

Authors:  C C Ton; H Hirvonen; H Miwa; M M Weil; P Monaghan; T Jordan; V van Heyningen; N D Hastie; H Meijers-Heijboer; M Drechsler
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

6.  A case of partial monosomy 21q22.2 associated with Rieger's syndrome.

Authors:  F Nielsen; L Trånebjaerg
Journal:  J Med Genet       Date:  1984-06       Impact factor: 6.318

Review 7.  Axenfeld-Rieger syndrome. A spectrum of developmental disorders.

Authors:  M B Shields; E Buckley; G K Klintworth; R Thresher
Journal:  Surv Ophthalmol       Date:  1985 May-Jun       Impact factor: 6.048

8.  Distal deletion of the short arm of chromosome 6.

Authors:  V L Zurcher; W L Golden; A B Zinn
Journal:  Am J Med Genet       Date:  1990-02

9.  Autosomal dominant iridogoniodysgenesis: genetic features.

Authors:  W G Pearce; H T Wyatt; T A Boyd; R S Ombres; A B Salter
Journal:  Can J Ophthalmol       Date:  1983-02       Impact factor: 1.882

10.  Autosomal dominant iridogoniodysgenesis: glaucoma management.

Authors:  H T Wyatt; W G Pearce; T A Boyd; R S Ombres; A B Salter
Journal:  Can J Ophthalmol       Date:  1983-02       Impact factor: 1.882

View more
  19 in total

1.  A novel mechanistic spectrum underlies glaucoma-associated chromosome 6p25 copy number variation.

Authors:  Bhaskar Chanda; Mika Asai-Coakwell; Ming Ye; Andrew J Mungall; Margaret Barrow; William B Dobyns; Hourinaz Behesti; Jane C Sowden; Nigel P Carter; Michael A Walter; Ordan J Lehmann
Journal:  Hum Mol Genet       Date:  2008-08-11       Impact factor: 6.150

2.  Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly.

Authors:  A J Mears; T Jordan; F Mirzayans; S Dubois; T Kume; M Parlee; R Ritch; B Koop; W L Kuo; C Collins; J Marshall; D B Gould; W Pearce; P Carlsson; S Enerbäck; J Morissette; S Bhattacharya; B Hogan; V Raymond; M A Walter
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

3.  Autosomal dominant Axenfeld-Rieger anomaly maps to 6p25.

Authors:  D B Gould; A J Mears; W G Pearce; M A Walter
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

4.  Familial glaucoma iridogoniodysplasia maps to a 6p25 region implicated in primary congenital glaucoma and iridogoniodysgenesis anomaly.

Authors:  T Jordan; N Ebenezer; R Manners; J McGill; S Bhattacharya
Journal:  Am J Hum Genet       Date:  1997-10       Impact factor: 11.025

5.  Mapping of a congenital microcoria locus to 13q31-q32.

Authors:  C Rouillac; O Roche; D Marchant; L Bachner; A Kobetz; P J Toulemont; C Orssaud; M Urvoy; S Odent; B Le Marec; M Abitbol; J L Dufier
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

Review 6.  The genetics of primary open angle glaucoma.

Authors:  A Booth; A Churchill; R Anwar; M Menage; A Markham
Journal:  Br J Ophthalmol       Date:  1997-05       Impact factor: 4.638

Review 7.  Molecular genetics of the glaucomas: mapping of the first five "GLC" loci.

Authors:  V Raymond
Journal:  Am J Hum Genet       Date:  1997-02       Impact factor: 11.025

Review 8.  Distal 6p deletion syndrome: a report of a case with anterior chamber eye anomaly and review of published reports.

Authors:  C J Law; A M Fisher; I K Temple
Journal:  J Med Genet       Date:  1998-08       Impact factor: 6.318

9.  Sequence analysis of MYOC and CYP1B1 in a Chinese pedigree of juvenile glaucoma with goniodysgenesis.

Authors:  Xiaoming Chen; Naihong Yan; Hongmin Yun; Jingjing Sun; Man Yu; Jiumo Zhou; Guiqun Cao; Hongbo Yin; Mao Li; Xuyang Liu
Journal:  Mol Vis       Date:  2009-08-07       Impact factor: 2.367

10.  A novel Asp380Ala mutation in the GLC1A/myocilin gene in a family with juvenile onset primary open angle glaucoma.

Authors:  A M Kennan; F C Mansergh; J H Fingert; T Clark; C Ayuso; P F Kenna; P Humphries; G J Farrar
Journal:  J Med Genet       Date:  1998-11       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.